Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
18 and older, Male and Female
The purpose of this signal seeking study is to determine whether
treatment with BGJ398 demonstrates sufficient efficacy in select FGFR
pathway-regulated solid tumors and/or hematologic malignancies to
warrant further study.
Treatment Sites in Georgia